Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in individuals with obesity or overweight without type 2 diabetes.
Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in individuals with obesity or overweight without type 2 diabetes.
Researchers are studying new medications that may help support weight loss and improve overall metabolic health.
This research study is evaluating an investigational study medication called RO7795068 (also known as CT-388). The purpose is to assess whether this medication can help reduce body weight and improve health outcomes in adults with obesity or overweight who do not have type 2 diabetes.
Participants will be randomly assigned to receive either RO7795068 or placebo. The study medication is given as a once-weekly injection, in addition to guidance on diet and physical activity.
Qualifications
Adults 18–65 with a history of high blood pressure that remains elevated despite treatment may qualify for a study evaluating
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a
Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in
Are you between 18 and 65 years old and being treated for depression? Even if your symptoms have improved, you
Suburban Research Associates is currently seeking participants 18 years or older who are struggling with generalized anxiety disorder for a
Suburban Research Associates in West Chester, PA is conducting a research study focused on Lyme disease prevention.